A	B	C
1	Main
2		Brand Name	Hepsera
3		Generic Name	adefovir
4		Indication	Hepatitis B (HBV). High incidence but low diagnosis.
5		Competition	Baraclude, Sebivo, 3TC (lamivudine)
6		Notes	Q206 GILD notes Baraclude gaining at the expense of 3TC
7		Price	8.5% price increase 8/1/08, 6.9% increase 1/1/08. $602?/m on Q2 2007 call.
8		Clinical Trials
9			Study 438
10
11
12		Rx
13			TRx
14		1/12/2007	3333
15		1/5/2007	3130